動態療法 (PDT) 市場規模、佔有率、成長分析（按機制、類別、治療方法、軟體、服務、應用程式可訪問性、應用和地區）- 產業預測，2025 年至 2032 年

全球動態療法 (PDT) 市場規模預計在 2023 年達到 41 億美元，從 2024 年的 49.3 億美元成長到 2032 年的 216.4 億美元，預測期內（2025-2032 年）的複合年成長率為 20.3%。

全球調查方法越來越受到對超越傳統方法的個人化、療效驅動型治療解決方案需求的影響。這種轉變源於人們日益認知到，客製化治療方案可提高患者參與度和臨床療效，從而最大限度地減少對傳統藥理學方法的依賴。由於監管機構建立了更清晰的核准途徑，因此光動力治療 (PDT) 被越來越廣泛地納入標準治療方案中。此外，越來越多的保險公司認知到 PDT 在管理慢性病和行為健康狀況方面的價值，從而推動了科技公司、醫療保健提供者和生命科學公司之間的合作。主要趨勢包括注重臨床檢驗、數位健康創新者與成熟醫療保健營業單位之間的夥伴關係，以及解決對資料隱私和安全的關鍵擔憂，以確保提供穩健的、以患者為中心的治療。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術分析
• 案例研究
• 顧客購買行為分析

動態療法 (PDT) 市場規模（按機制和複合年成長率） (2025-2032)

• 市場概覽
• 輸入機制
• 輸出機制

動態療法 (PDT) 市場規模（按類別）及複合年成長率（2025-2032）

• 市場概覽
• 藥物增強
• 藥物替代

動態療法 (PDT) 市場規模：依治療方法和複合年成長率（2025-2032 年）

• 市場概覽
• 門診治療
• 單藥治療

動態療法 (PDT) 市場規模（按軟體和複合年成長率） (2025-2032)

• 市場概覽
• 呼吸疾病軟體
• 心理健康軟體
• 鴉片類藥物使用疾患軟體
• 糖尿病軟體
• 其他

動態療法 (PDT) 市場規模（按服務類型和複合年成長率） (2025-2032)

• 市場概覽
• 行為微服務
• 醫療微服務

動態療法 (PDT) 市場規模（按應用可近性及複合年成長率）(2025-2032)

• 市場概覽
• Android
• iOS
• Windows

動態療法 (PDT) 市場規模（按應用類型和複合年成長率）（2025-2032）

• 市場概覽
• 原生應用
• Web 應用程式

動態療法（PDT）市場規模：按應用和複合年成長率（2025-2032）

• 市場概覽
• 物質使用疾患（SUD）
• 鴉片類藥物使用疾患（OUD）
• 注意力不足過動症（ADHD）
• 阿茲海默症
• 重度憂鬱症（MDD）
• 失眠
• 癲癇
• 運動障礙
• 多發性硬化症
• 偏頭痛
• 泛自閉症障礙
• 腫瘤學
• 發炎
• 呼吸系統
• 心血管系統
• 疼痛管理
• 代謝狀態
• 其他

動態療法（PDT）市場規模：依病患分類及複合年成長率（2025-2032）

• 市場概覽
• 孩子
• 成人

動態療法（PDT）市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 按部門分類的公司佔有率分析
  • 收益同比對比（2022-2024 年）

主要企業簡介

• ResMed（US）
• SAMSUNGHEALTHCARE（South Korea）
• Novartis AG（Switzerland）
• Medtronic（Ireland）
• Omada Health, Inc.（US）
• GAIA AG（Germany）
• Welldoc's Bluestar（US）
• Better Therapeutics, LLC（US）
• BigHealth（US）
• Biofourmis（US）
• Click Therapeutics, Inc.（US）
• Happify, Inc.（US）
• Naturalcycles Nordic AB（Sweden）
• NuvoAir AB（Sweden）
• Sensyne Health plc.（UK）

結論和建議

Global Photodynamic Therapy (PDT) Market size was valued at USD 4.1 billion in 2023 and is poised to grow from USD 4.93 billion in 2024 to USD 21.64 billion by 2032, growing at a CAGR of 20.3% during the forecast period (2025-2032).

The global Photodynamic Therapy (PDT) landscape is increasingly influenced by the demand for personalized and efficacy-driven treatment solutions that transcend conventional methodologies. This shift stems from a growing acknowledgment that customized therapeutic programs enhance patient engagement and clinical results, minimizing dependence on traditional pharmacological approaches. Integration of PDT into standard care routines is becoming prevalent, facilitated by clearer approval pathways established by regulatory agencies. Additionally, insurance providers are increasingly recognizing the value of PDT in managing both chronic and behavioral health conditions, driving collaborative efforts among tech companies, healthcare providers, and life-science firms. Key trends include a focus on clinical validation and partnerships between digital health innovators and established healthcare entities, addressing critical concerns around data privacy and security to ensure robust, patient-focused therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Photodynamic Therapy (PDT) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Photodynamic Therapy (PDT) Market Segments Analysis

Global Photodynamic Therapy (PDT) Market is segmented by Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients and region. Based on Mechanism, the market is segmented into Input Mechanisms and Output Mechanisms. Based on Category, the market is segmented into Medication Augmentation and Medication Replacement. Based on Treatment, the market is segmented into Outpatient Treatment and Monotherapy. Based on Software, the market is segmented into Software for Respiratory Conditions, Software for Mental Health, Software for Opioid Use Disorder, Software for Diabetes and Others. Based on Services, the market is segmented into Behavioral Microservices and Medical Microservices. Based on App Accessibility, the market is segmented into Android, iOS and Windows. Based on App Type, the market is segmented into Native Apps and Web Apps. Based on Application, the market is segmented into Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer's Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions and Others. Based on Patients, the market is segmented into Children and Adults. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Photodynamic Therapy (PDT) Market

The increasing focus on patient-centric care is significantly driving growth in the global Photodynamic Therapy (PDT) market. There is a heightened demand for therapeutic solutions that prioritize personalized support rather than relying solely on traditional medications. Prescription digital therapeutics are gaining traction, offering structured and evidence-based programs that can be tailored to the unique requirements of each patient. This evolution is particularly essential for the management of chronic and behavioral health issues, where ongoing engagement and real-time feedback play a crucial role. As patients' expectations shift, the attractiveness of customized, technology-driven treatment options continues to expand.

Restraints in the Global Photodynamic Therapy (PDT) Market

Despite the increasing interest in photodynamic therapy (PDT), there is still a significant lack of awareness among healthcare providers and patients regarding its clinical benefits and accessibility. This unfamiliarity contributes to reluctance in adopting PDT, resulting in lower prescription rates. Furthermore, the available training and educational resources are insufficient, hindering the integration of PDT into standard treatment practices. Without a deeper understanding among key stakeholders, the market potential for PDT remains largely untapped, as misconceptions and a lack of knowledge impede its acceptance and implementation in therapeutic settings.

Market Trends of the Global Photodynamic Therapy (PDT) Market

The Global Photodynamic Therapy (PDT) market is experiencing a transformative trend driven by the integration of drug-digital combination therapies. Pharmaceutical companies are forging partnerships with digital therapeutic developers to create innovative solutions that combine PDT with software-based interventions. This synergistic approach enhances treatment efficacy by modifying both patient behavior and pharmacological responses simultaneously. The incorporation of digital tools not only aids in adherence tracking but also facilitates the collection of real-world data, leading to improved therapeutic outcomes. As the demand for personalized medicine and enhanced patient care continues to rise, the PDT market is poised for significant growth, characterized by this collaborative evolution.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Photodynamic Therapy (PDT) Market Size by Mechanism & CAGR (2025-2032)

• Market Overview
• Input Mechanisms
• Output Mechanisms

Global Photodynamic Therapy (PDT) Market Size by Category & CAGR (2025-2032)

• Market Overview
• Medication Augmentation
• Medication Replacement

Global Photodynamic Therapy (PDT) Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Outpatient Treatment
• Monotherapy

Global Photodynamic Therapy (PDT) Market Size by Software & CAGR (2025-2032)

• Market Overview
• Software for Respiratory Conditions
• Software for Mental Health
• Software for Opioid Use Disorder
• Software for Diabetes
• Others

Global Photodynamic Therapy (PDT) Market Size by Services & CAGR (2025-2032)

• Market Overview
• Behavioral Microservices
• Medical Microservices

Global Photodynamic Therapy (PDT) Market Size by App Accessibility & CAGR (2025-2032)

• Market Overview
• Android
• iOS
• Windows

Global Photodynamic Therapy (PDT) Market Size by App Type & CAGR (2025-2032)

• Market Overview
• Native Apps
• Web Apps

Global Photodynamic Therapy (PDT) Market Size by Application & CAGR (2025-2032)

• Market Overview
• Substance Use Disorder (SUD)
• Opioid Use Disorder (OUD)
• Attention Deficit/Hyperactivity Disorder (ADHD)
• Alzheimer's Disease
• Major Depressive Disorder (MDD)
• Insomnia
• Epilepsy
• Movement Disorder
• Multiple Sclerosis
• Migraine
• Autism Spectrum Disorder
• Oncology
• Inflammation
• Respiratory
• Cardiovascular
• Pain Management
• Metabolic Conditions
• Others

Global Photodynamic Therapy (PDT) Market Size by Patients & CAGR (2025-2032)

• Market Overview
• Children
• Adults

Global Photodynamic Therapy (PDT) Market Size & CAGR (2025-2032)

• North America (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • US
  • Canada
• Europe (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• ResMed (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAMSUNGHEALTHCARE (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omada Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GAIA AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Welldoc's Bluestar (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Better Therapeutics, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BigHealth (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biofourmis (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Click Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Happify, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Naturalcycles Nordic AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuvoAir AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensyne Health plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations